INTERNATIONAL PATENT: ALIGOS THERAPEUTICS, INC. FILES APPLICATION FOR "ORAL FORMULATIONS OF THR-BETA AGONIST"

GENEVA, April 20 -- ALIGOS THERAPEUTICS, INC. (1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/050334) for "ORAL FORMULATIONS OF THR-BETA AGONIST" on Oct 09, 2025. With publication no. WO/2026/080750, the details related to the patent application was published on Apr 16, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAI, Felix ShangChung (c/o ALIGOS THERAPEUTICS, INC.1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080), VENKATRAMAN, Meenakshi (c/o ALIGOS THERAPEUTICS, INC.1 Corporate Drive, 2nd FloorSouth San Francisco...